| Entry |
|
|---|
| Name |
Norethindrone (USP);
Norethisterone (JP18);
Camila (TN);
Micronor (TN);
Primolut-N (TN) |
|---|
| Product |
|
|---|
| Generic |
AFFODEL (Naari Pte. Limited), CAMILA (Dr. Reddy's Labratories), CAMILA (Mayne Pharma), DEBLITANE (Northstar Rx LLC), EMZAHH (Aurobindo Pharma Limited), ERRIN (Dr. Reddy's Labratories), ERRIN (Mayne Pharma), ERRIN (Proficient Rx LP), HEATHER (Glenmark Pharmaceuticals), INCASSIA (Aurobindo Pharma Limited), JENCYCLA (Lupin Pharmaceuticals), LYLEQ (Afaxys Pharma), LYLEQ (RPK Pharmaceuticals), NORA BE (Actavis Pharma), NORA BE (Teva Pharmaceuticals), NORETHINDRONE (A-S Medication Solutions), NORETHINDRONE (Glenmark Pharmaceuticals), NORETHINDRONE (Lupin Pharmaceuticals), NORETHINDRONE (Mylan Pharmaceuticals), NORETHINDRONE (Mylan Pharmaceuticals), NORETHINDRONE (Proficient Rx LP), NORLYDA (A-S Medication Solutions), NORLYDA (Amneal Pharmaceuticals NY LLC), SHAROBEL (Northstar Rx LLC) |
|---|
| Formula |
C20H26O2
|
|---|
| Exact mass |
298.1933
|
|---|
| Mol weight |
298.42
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Hormonal agent
DG02004 Progesterone
DG01666 Progesterone receptor agonist
|
|---|
| Remark |
| Therapeutic category: | 2479 |
| Product (DG00456): | D00182<JP/US> D00953<US> |
| Product (mixture): | D04483<JP/US> D09188<JP/US> |
|
|---|
| Efficacy |
Contraceptive, Progesterone receptor agonist |
|---|
| Comment |
Progestin, Estren derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04914 | Progesterone-mediated oocyte maturation |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07226 | Progesterone, androgen and estrogen receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
G03AC Progestogens
G03AC01 Norethisterone
D00182 Norethindrone (USP) <JP/US>
G03D PROGESTOGENS
G03DC Estren derivatives
G03DC02 Norethisterone
D00182 Norethindrone (USP) <JP/US>
USP drug classification [BR:br08302]
Contraceptives
Oral Progestins
Norethindrone
D00182 Norethindrone (USP)
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Progestins
Norethindrone
D00182 Norethindrone (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
247 Estrogen and progesterone preparations
2479 Others
D00182 Norethindrone (USP); Norethisterone (JP18)
Drug groups [BR:br08330]
Hormonal agent
DG02004 Progesterone
DG00456 Norethisterone
D00182 Norethindrone
DG01666 Progesterone receptor agonist
DG00456 Norethisterone
D00182 Norethindrone
Drug classes [BR:br08332]
Endocrine and hormonal agent
DG02004 Progesterone
D00182 Norethindrone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C3 (PGR)
D00182 Norethindrone (USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00182 Norethisterone
Drug groups [BR:br08330]
Hormonal agent
DG02004 Progesterone
DG00456 Norethisterone
DG01666 Progesterone receptor agonist
DG00456 Norethisterone
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 22
1 C1y C 26.8452 -17.3412
2 C1z C 26.8512 -15.9656
3 C1y C 25.6547 -18.0321
4 C1x C 29.2262 -17.3473
5 C1z C 28.0417 -15.2747
6 C1x C 25.6484 -15.2810
7 C1a C 26.8019 -14.4420
8 C1y C 24.4702 -17.3536
9 C1x C 25.5970 -19.4015
10 C1x C 29.2324 -15.9718
11 C3b C 29.1954 -14.5962
12 O1a O 28.0357 -13.5161
13 C1x C 24.5279 -15.9779
14 C1y C 23.2921 -18.0384
15 C1x C 24.4826 -20.0800
16 C3a C 30.3488 -13.9116
17 C2y C 23.2921 -19.3954
18 C1x C 22.1200 -17.3720
19 C2x C 22.1200 -20.0800
20 C1x C 20.9542 -18.0384
21 C5x C 20.9542 -19.3954
22 O5x O 19.7884 -20.0616
BOND 25
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 2 7 1 #Up
7 3 8 1
8 3 9 1
9 4 10 1
10 5 11 1 #Down
11 5 12 1 #Up
12 6 13 1
13 8 14 1
14 9 15 1
15 11 16 3
16 14 17 1
17 14 18 1
18 17 19 2
19 18 20 1
20 19 21 1
21 21 22 2
22 5 10 1
23 8 13 1
24 15 17 1
25 20 21 1
|
|---|
